Cargando…

Adenosine A(2A) Receptor Binding Profile of Two Antagonists, ST1535 and KW6002: Consideration on the Presence of Atypical Adenosine A(2A) Binding Sites

Adenosine A(2A) receptors seem to exist in typical (more in striatum) and atypical (more in hippocampus and cortex) subtypes. In the present study, we investigated the affinity of two adenosine A(2A) receptor antagonists, ST1535 [2 butyl -9-methyl-8-(2H-1,2,3-triazol 2-yl)-9H-purin-6-xylamine] and K...

Descripción completa

Detalles Bibliográficos
Autores principales:	Riccioni, Teresa, Leonardi, Fabiana, Borsini, Franco
Formato:	Texto
Lenguaje:	English
Publicado:	Frontiers Research Foundation 2010
Materias:	Psychiatry
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3059644/ https://www.ncbi.nlm.nih.gov/pubmed/21423433 http://dx.doi.org/10.3389/fpsyt.2010.00022

Ejemplares similares

The adenosine A(2A) receptor antagonist KW6002 distinctly regulates retinal ganglion cell morphology during postnatal development and neonatal inflammation
por: Hu, Shisi, et al.
Publicado: (2022)

Treatment with A(2A) receptor antagonist KW6002 and caffeine intake regulate microglia reactivity and protect retina against transient ischemic damage
por: Boia, Raquel, et al.
Publicado: (2017)

Computational studies of the binding modes of A(2A) adenosine receptor antagonists
por: Ye, Y., et al.
Publicado: (2007)

Structural and Energetic Effects of A(2A) Adenosine Receptor Mutations on Agonist and Antagonist Binding
por: Keränen, Henrik, et al.
Publicado: (2014)

Binding of the Antagonist Caffeine to the Human Adenosine Receptor hA(2A)R in Nearly Physiological Conditions
por: Cao, Ruyin, et al.
Publicado: (2015)

Irreversible Antagonists for the Adenosine A(2B) Receptor †
por: Temirak, Ahmed, et al.
Publicado: (2022)

X‐Ray Crystallography and Free Energy Calculations Reveal the Binding Mechanism of A(2A) Adenosine Receptor Antagonists
por: Jespers, Willem, et al.
Publicado: (2020)

A covalent antagonist for the human adenosine A(2A) receptor
por: Yang, Xue, et al.
Publicado: (2016)

Pathways and Mechanism of Caffeine Binding to Human Adenosine A(2A) Receptor
por: Do, Hung N., et al.
Publicado: (2021)

Tumor Immunotherapy Using A(2A) Adenosine Receptor Antagonists
por: Zhang, Jinfeng, et al.
Publicado: (2020)

A(2B) adenosine receptor antagonists rescue lymphocyte activity in adenosine-producing patient-derived cancer models
por: Tay, Apple Hui Min, et al.
Publicado: (2022)

Calcium and Adenosine Triphosphate Binding to Renal Membranes
por: Palmer, Roger F., et al.
Publicado: (1970)

Effect of Adenosine Receptor Antagonists on Adenosine-Pretreated PC12 Cells Exposed to Paraquat
por: Shang, Liangcheng, et al.
Publicado: (2022)

Human Adenosine A(2A) Receptor: Molecular Mechanism of Ligand Binding and Activation
por: Carpenter, Byron, et al.
Publicado: (2017)

PBF509, an Adenosine A(2A) Receptor Antagonist With Efficacy in Rodent Models of Movement Disorders
por: Núñez, Fabiana, et al.
Publicado: (2018)

Identification of Novel Adenosine A(2A) Receptor Antagonists by Virtual Screening
por: Langmead, Christopher J., et al.
Publicado: (2012)

Striatal Pre- and Postsynaptic Profile of Adenosine A(2A) Receptor Antagonists
por: Orru, Marco, et al.
Publicado: (2011)

A(2A) Adenosine Receptor Antagonists: Are Triazolotriazine and Purine Scaffolds Interchangeable?
por: Spinaci, Andrea, et al.
Publicado: (2022)

Impact of an Adenosine A(2A) Receptor Agonist and Antagonist on Binding of the Dopamine D(2) Receptor Ligand [(11)C]raclopride in the Rodent Striatum
por: Prasad, Kavya, et al.
Publicado: (2022)

Asymmetric interactions in the adenosine-binding pockets of the MS2 coat protein dimer
por: Powell, Amy J, et al.
Publicado: (2001)

The Pharmacological Potential of Adenosine A(2A) Receptor Antagonists for Treating Parkinson’s Disease
por: Mori, Akihisa, et al.
Publicado: (2022)

Pharmacological characterisation of novel adenosine A(3) receptor antagonists
por: Barkan, Kerry, et al.
Publicado: (2020)

Mass spectrometry-based ligand binding assays on adenosine A(1) and A(2A) receptors
por: Massink, A., et al.
Publicado: (2015)

Revisiting the Allosteric Regulation of Sodium Cation on the Binding of Adenosine at the Human A(2A) Adenosine Receptor: Insights from Supervised Molecular Dynamics (SuMD) Simulations
por: Bissaro, Maicol, et al.
Publicado: (2019)

The RNA binding domain of Pumilio antagonizes poly-adenosine binding protein and accelerates deadenylation
por: Weidmann, Chase A., et al.
Publicado: (2014)

Novel selective antagonist radioligands for the pharmacological study of A(2B) adenosine receptors
por: Gessi, Stefania, et al.
Publicado: (2006)

Computerized Modeling of Adenosine Triphosphate, Adenosine Triarsenate and Adenosine Trivanadate
por: Nascimento, Valter A., et al.
Publicado: (2012)

Adenosine-Metabolizing Enzymes, Adenosine Kinase and Adenosine Deaminase, in Cancer
por: Zhulai, Galina, et al.
Publicado: (2022)

The dynamics of t1 adenosine binding on human Argonaute 2: Understanding recognition with conformational selection
por: Rinaldi, Silvia, et al.
Publicado: (2022)

Adenosine Receptors as Neuroinflammation Modulators: Role of A(1) Agonists and A(2A) Antagonists
por: Martí Navia, Aleix, et al.
Publicado: (2020)

Effect of adenosine and adenosine receptor antagonist on Müller cell potassium channel in Rat chronic ocular hypertension models
por: Yang, Zijian, et al.
Publicado: (2015)

Fluorinated Adenosine A(2A) Receptor Antagonists Inspired by Preladenant as Potential Cancer Immunotherapeutics
por: Yuan, Gengyang, et al.
Publicado: (2017)

Adenosine A(2A) Receptor Antagonists in Neurodegenerative Diseases: Huge Potential and Huge Challenges
por: Franco, Rafael, et al.
Publicado: (2018)

Pathophysiological Role and Medicinal Chemistry of A(2A) Adenosine Receptor Antagonists in Alzheimer’s Disease
por: Merighi, Stefania, et al.
Publicado: (2022)

Atypical Omenn Syndrome due to Adenosine Deaminase Deficiency
por: Joshi, Avni Y., et al.
Publicado: (2012)

Structural Basis for Binding of Allosteric Drug Leads in the Adenosine A(1) Receptor
por: Miao, Yinglong, et al.
Publicado: (2018)

Atypical presentation of adenosine deaminase 2 deficiency with bi‐allelic ADA2 mutation
por: Al‐shaikh, Reem, et al.
Publicado: (2022)

Characterization of human and rodent native and recombinant adenosine A(2B) receptors by radioligand binding studies
por: Bertarelli, Daniela C. G., et al.
Publicado: (2006)

Synthesis of Novel Fluorinated Xanthine Derivatives with High Adenosine A(2B) Receptor Binding Affinity
por: Lindemann, Marcel, et al.
Publicado: (2021)

How Are Adenosine and Adenosine A(2A) Receptors Involved in the Pathophysiology of Amyotrophic Lateral Sclerosis?
por: Mori, Akihisa, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_n2cf364mqn317ea0bo31reec8d